💊Takara Bio, launched quality test kit for products such as regenerative medicine
💊Kyowa Hakko Kirin, anti-Ccr4 humanized antibody acceptance application for European approval of Mogum Lysumab 20171027
Category: Pharmaceutical
💊Takara Bio acquires exclusive license with new iPS cell production method
💊Dainippon Sumitomo announces the launch of “Seebri ™ Neohaler®” for the treatment of chronic obstructive pulmonary disease (COPD) in the United States 20171020
💊Establish mass production technology of Toyobo and HMT, enzymes for depression related biomarkers Toyobo and Human Metabolome Technologies have established mass-production technologies for enzymes used for measuring depression-related biomarkers through collaborative research.